VOYA INVESTMENT MANAGEMENT LLC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1068837 ATLANTA, GA

Position in SPRY

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$468,735

+$71,145 QoQ

Shares Held

58,373

+71.0% QoQ

Ownership

0.059%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 0% Shared 17% None 83%

Healthcare · as of Mar 31, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,306,795,205 across 174 Biotechnology names. SPRY ranks #102 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	349,912	$270,356,007
2	VRTX	Vertex Pharmaceuticals Inc / Ma	527,047	$235,347,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	148,488	$49,130,223
4	PTGX	Protagonist Therapeutics, Inc	454,383	$47,891,967
5	ARWR	Arrowhead Pharmaceuticals, Inc.	656,129	$41,139,286
6	BBIO	BridgeBio Pharma, Inc.	538,980	$40,024,653
7	INSM	INSMED Inc	243,706	$39,850,804
8	SRRK	Scholar Rock Holding Corp	725,409	$35,661,105

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$468,735	58,373	+71.0%	Shares	Defined	2026-05-12
2025-12-31	$397,590	34,128	-70.3%	Shares	Defined	2026-02-12
2025-09-30	$1,154,271	114,853	-30.9%	Shares	Defined	2025-10-09
2025-06-30	$2,899,910	166,184	+152.9%	Shares	Defined	2025-08-14
2025-03-31	$826,794	65,723	-2.3%	Shares	Defined	2025-06-18
2024-12-31	$709,772	67,277	+40.5%	Shares	Defined	2025-05-02
2024-09-30	$694,492	47,896	+176.7%	Shares	Defined	2025-02-07
2024-06-30	$147,282	17,307	+223.5%	Shares	Defined	2025-02-07
2021-03-31	$233,420	5,350	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.